{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33321518", "DateCompleted": {"Year": "2021", "Month": "02", "Day": "04"}, "DateRevised": {"Year": "2021", "Month": "02", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.1055/a-1315-2282"], "Journal": {"ISSN": "1439-0221", "JournalIssue": {"Volume": "87", "Issue": "1-02", "PubDate": {"Year": "2021", "Month": "Feb"}}, "Title": "Planta medica", "ISOAbbreviation": "Planta Med"}, "ArticleTitle": "Precursor-directed Biosynthesis in Tabernaemontana catharinensis as a New Avenue for Alzheimer's Disease-modifying Agents.", "Pagination": {"StartPage": "136", "EndPage": "147", "MedlinePgn": "136-147"}, "Abstract": {"AbstractText": ["Plants produce a high diversity of metabolites that can act as regulators of cholinergic dysfunction. Among plants, the potential of species of the genus <i>Tabernaemontana</i> to treat neurological disorders has been linked to iboga-type alkaloids that are biosynthesized by those species. In this context, precursor-directed biosynthesis approaches were carried out using <i>T. catharinensis</i> plantlets to achieve new-to-nature molecules as promising agents against Alzheimer's disease. Aerial parts of <i>T. catharinensis</i>, cultured in vitro, produced 7 unnatural alkaloids (5-fluoro-ibogamine, 5-fluoro-voachalotine, 5-fluoro-12-methoxy-Nb-methyl-voachalotine, 5-fluoro-isovoacangine, 5-fluoro-catharanthine, 5-fluoro-19-(S)-hydroxy-ibogamine, and 5-fluoro-coronaridine), while root extracts showed the presence of the same unnatural iboga-type alkaloids and 2 additional ones: 5-fluoro-voafinine and 5-fluoro-affinisine. Moreover, molecular docking approaches were carried out to evaluate the potential inhibition activity of <i>T. catharinensis</i>' natural and unnatural alkaloids against AChE and BChE enzymes. Fluorinated iboga alkaloids (5-fluoro-catharanthine, 5-fluoro-voachalotine, 5-fluoro-affinisine, 5-fluoro-isovoacangine, 5-fluoro-corinaridine) were more active than natural ones and controls against AchE, while 5-fluoro-19-(S)-hydroxy-ibogamine, 5-fluoro-catharanthine, 5-fluoro-isovoacangine, and 5-fluoro-corinaridine showed better activity than natural ones and controls against BChE. Our findings showed that precursor-directed biosynthesis strategies generated \"new-to-nature\" alkaloids that are promising Alzheimer's disease drug candidates. Furthermore, the isotopic experiments also allowed us to elucidate the initial steps of the biosynthetic pathway for iboga-type alkaloids, which are derived from the MEP and shikimate pathways."], "CopyrightInformation": "Thieme. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Unit, University of Ribeir\u00e3o Preto (UNAERP), Ribeir\u00e3o Preto, SP, Brazil."}], "LastName": "Musquiari", "ForeName": "Bruno", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Philosophy, Sciences and Letters at Ribeir\u00e3o Preto, Universidade de S\u00e3o Paulo (USP), Ribeir\u00e3o Preto, SP, Brazil."}], "LastName": "Crevelin", "ForeName": "Eduardo J", "Initials": "EJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Unit, University of Ribeir\u00e3o Preto (UNAERP), Ribeir\u00e3o Preto, SP, Brazil."}, {"Identifier": [], "Affiliation": "Botanic Garden of Medicinal Plant Ordem e Progresso (BOP), Jardin\u00f3polis, SP, Brazil."}], "LastName": "Bertoni", "ForeName": "Bianca W", "Initials": "BW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Unit, University of Ribeir\u00e3o Preto (UNAERP), Ribeir\u00e3o Preto, SP, Brazil."}], "LastName": "Fran\u00e7a", "ForeName": "Suzelei de C", "Initials": "SC"}, {"Identifier": ["0000-0002-3478-4718"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Unit, University of Ribeir\u00e3o Preto (UNAERP), Ribeir\u00e3o Preto, SP, Brazil."}, {"Identifier": [], "Affiliation": "Botanic Garden of Medicinal Plant Ordem e Progresso (BOP), Jardin\u00f3polis, SP, Brazil."}], "LastName": "Pereira", "ForeName": "Ana Maria S", "Initials": "AMS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State University of Campinas (UNICAMP), Institute of Biology, Department of Botany, Campinas, SP, Brazil."}], "LastName": "Castello", "ForeName": "Ana Carolina Devides", "Initials": "ACD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Natural Sciences, Exacts and Education, University of Cauca, Popay\u00e1n Colombia."}], "LastName": "Castillo-Ordo\u00f1ez", "ForeName": "Willian O", "Initials": "WO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics, Ribeir\u00e3o Preto Medical School, University of S\u00e3o Paulo (USP), Ribeir\u00e3o Preto, SP, Brazil."}], "LastName": "Giuliatti", "ForeName": "Silvana", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Unit, University of Ribeir\u00e3o Preto (UNAERP), Ribeir\u00e3o Preto, SP, Brazil."}], "LastName": "Lopes", "ForeName": "Adriana A", "Initials": "AA"}], "GrantList": [{"GrantID": "Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior", "Agency": "Grant #88882.365148/2019-01", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Planta Med", "NlmUniqueID": "0066751", "ISSNLinking": "0032-0943"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Indole Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "affinisine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Alkaloids"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Indole Alkaloids"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Tabernaemontana"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "12", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "15", "Hour": "20", "Minute": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33321518", "10.1055/a-1315-2282"]}}]}